Novo Nordisk A/S (NYSE:NVO) Upgraded by Wall Street Zen to “Buy” Rating
Novo Nordisk A/S (NYSE:NVO – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. NVO has been the topic of several other reports. BMO Capital Markets restated a “market perform” rating and set a $64.00 target price (down […]
Novo Nordisk A/S (NYSE:NVO – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. NVO has been the topic of several other reports. BMO Capital Markets restated a “market perform” rating and set a $64.00 target price (down […]
